Research and Markets – Cytokine-Based Research Continues to Revolutionise the Treatment of Inflammatory, Infectious, and Neoplastic Diseases

(PRWEB) November 15, 2004 Research and Markets (http://www.researchandmarkets.com/reports/c9215) has announced the addition of Cytokines, Chemokines, and Growth Factors- Key Targets for Immunotherapeutic Development to their offering. The cytokines, chemokines, and growth factors market has $ 90 billion revenue potential. Cytokine-based research is revolutionizing the treatment of inflammatory, infectious, and neoplastic diseases. Many of the ...